Virginia Byers Kraus, MD, PhD

Professor of Medicine
Professor of Pathology
Professor in Orthopaedic Surgery
Member of Duke Molecular Physiology Institute
Affiliate of the Regeneration Next Initiative
Campus mail 300 N Duke St, Carmichael Building Room 15-205, Durham, NC 27701-2047
Phone (919) 681-6652
Email address

My special area of expertise is as a clinician scientist investigating osteoarthritis. Osteoarthritis is the most common form of joint disease in man and its incidence increases with age. It is a problem of increasing concern to the medical community due to the increasing longevity of the population. Trained as a molecular biologist and a Rheumatologist, I endeavor to study this disease from bedside to bench.

The work in this laboratory focuses on osteoarthritis and deals with the mechanisms of joint damage, and the discovery, validation and qualification of novel biochemical and genetic biomarkers for minimally invasive means of diagnosing disease, for predicting progression of disease, and for monitoring disease progression and response to therapy.

Education and Training

  • Fellow in Rheumatology, Medicine, Duke University, 1986 - 1989
  • Medical Resident, Medicine, Duke University, 1983 - 1986
  • Ph.D., Duke University, 1993
  • M.D., Duke University, 1982


Stabler, T. V., E. Montell, J. Vergés, J. L. Huebner, and V. B. Kraus. “Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation?.” In Biomarker Insights, Vol. 12, 2017.

Full Text

Deveza, Leticia A., Virginia B. Kraus, Jamie E. Collins, Ali Guermazi, Frank W. Roemer, Michael Bowes, Michael C. Nevitt, Christoph Ladel, and David J. Hunter. “Association Between Biochemical Markers of Bone Turnover and Bone Changes on Imaging: Data From the Osteoarthritis Initiative..” Arthritis Care Res (Hoboken) 69, no. 8 (August 2017): 1179–91.

Full Text

Nwosu, L. N., M. Allen, L. Wyatt, J. L. Huebner, V. Chapman, D. A. Walsh, and V. B. Kraus. “Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA..” Osteoarthritis Cartilage 25, no. 6 (June 2017): 858–65.

Full Text

Montell, E., T. V. Stabler, and V. B. Kraus. “THU0044 Chondroitin sulphate inhibits monocyte chemoattractant protein-1 release from 3T3L1 adipocytes: a new treatment opportunity for obesity-related metabolic syndromes?.” In Poster Presentations. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017.

Full Text

Liu, Betty, Adam P. Goode, Teralyn E. Carter, Gangadhar M. Utturkar, Janet L. Huebner, Dean C. Taylor, Claude T. Moorman, et al. “Matrix metalloproteinase activity and prostaglandin E2 are elevated in the synovial fluid of meniscus tear patients..” Connect Tissue Res 58, no. 3–4 (May 2017): 305–16.

Full Text

Adams, Samuel B., Elizabeth M. Leimer, Lori A. Setton, Richard D. Bell, Mark E. Easley, Janet L. Huebner, Thomas V. Stabler, Virginia B. Kraus, Steven A. Olson, and Dana L. Nettles. “Inflammatory Microenvironment Persists After Bone Healing in Intra-articular Ankle Fractures..” Foot Ankle Int 38, no. 5 (May 2017): 479–84.

Full Text

Furman, B. D., K. A. Kimmerling, S. Ramamoorthy, Y. -. J. Li, Y. -. H. Wu, J. L. Huebner, F. Guilak, V. B. Kraus, and S. A. Olson. “Articular fracture upregulates lipid metabolites in human synovial fluid.” In Osteoarthritis and Cartilage, 25:S381–S381. Elsevier BV, 2017.

Full Text

Conaghan, P., V. Strand, D. Hunter, V. B. Kraus, F. Berenbaum, N. P. Katz, J. Lufkin, J. R. Johnson, S. Kelley, and N. Bodick. “An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials.” In Osteoarthritis and Cartilage, 25:S432–33. Elsevier BV, 2017.

Full Text

Montell, E., T. V. Stabler, J. Vergés, and V. B. Kraus. “Chondroitin Sulphate Inhibits Monocyte Chemoattractant Protein-1 Release from 3T3L1 Adipocytes: A New Treatment Opportunity for Obesity-related Metabolic Syndromes?.” In Osteoarthritis and Cartilage, 25:S272–S272. Elsevier BV, 2017.

Full Text